Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
New Zealand Insulin Drugs And Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... million in 2023 to USD 546.59 million by 2028, at a CAGR of 1.10% during the forecast period (2023-2028). After COVID-19 was detected, the risk of developing type 1 diabetes increased. The largest risk was ... Read More
-
Asia-Pacific Insulin Infusion Pumps Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 393.41 million by 2028, growing at a CAGR of 4.65% during the forecast period (2023-2028). People with Covid-19 had a statistically greater incidence of type 2 diabetes and other kinds of diabetes ... Read More
-
Saudi Arabia Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023 to USD 788 million by 2028, at a CAGR of 4.33% during the forecast period (2023-2028). In Riyadh, hospitalized COVID-19 patients had a significant frequency of diabetes mellitus. Even though people with diabetes have ... Read More
-
Europe Insulin Syringe Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 117.35 million by 2028, growing at a CAGR of 1.20% during the forecast period (2023-2028). The COVID-19 pandemic has substantially impacted the Europe Insulin Syringe Market. People with diabetes have a weak immune system ... Read More
-
Italy Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 1.27 billion by 2028, growing at a CAGR of 6.70% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly ... Read More
-
Human Recombinant Insulin Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 31.92 billion by 2028, at a CAGR of 2.90% during the forecast period (2023-2028). COVID-19 is expected to drive the growth of the market during the forecast period. The increased risk for diabetes patients during ... Read More
-
Basal Insulin Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 328.87 million by 2028, growing at a CAGR of 4.70% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 4.9 billion during the forecast period. The COVID-19 ... Read More
-
Short-Acting Insulin Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2028, at a CAGR of 3.46% during the forecast period (2023-2028). There is not enough data saying that diabetes people are more likely to get COVID-19 than other healthy people, individuals with any kind of ... Read More
-
Egypt Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... million by 2028, at a CAGR of 3% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 730 million by 2027. The COVID-19 pandemic positively impacted the ... Read More
-
Germany Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion by 2028, at a CAGR of 3.47% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly among older individuals. Most people ... Read More
-
Russia Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 1.54 billion by 2028, growing at a CAGR of 4.53% during the forecast period (2023-2028). Within the first year since its inception, the COVID-19 pandemic has been responsible for premature deaths, particularly ... Read More
-
Indonesia Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 175 million by 2028, at a CAGR of 5.73% during the forecast period (2023-2028). The coronavirus disease 2019 (COVID-19) pandemic is a massive worldwide public health disaster caused by the severe acute respiratory syndrome ... Read More
-
Brazil Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 1.32 billion by 2028, growing at a CAGR of 5.62% during the forecast period (2023-2028). The COVID-19 pandemic has had a notable impact on the diabetes care devices market. Diabetes is a ... Read More
-
France Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 1.68 billion by 2028, growing at a CAGR of 6.58% during the forecast period (2023-2028). One of the most significant risk factors for a severe course of COVID-19 is diabetes mellitus. This risk is ... Read More
-
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GlL[-1) Receptor Agonist Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... size is expected to grow from USD 9.20 billion in 2023 to USD 11.52 billion by 2028, at a CAGR of 4.61% during the forecast period (2023-2028). The COVID-19 epidemic has significantly affected the market ... Read More
-
Insulin Glargine Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 1.97 billion by 2028, growing at a CAGR of 6.28% during the forecast period (2023-2028). The COVID-19 pandemic has resulted in a surge in diabetic complexities, which is driving the insulin demand in the market. ... Read More
-
United Kingdom (UK) Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 1.20 billion by 2028, at a CAGR of 3.05% during the forecast period (2023-2028). The COVID-19 pandemic has had a substantial impact on the United Kingdom's diabetes drugs market. According to The British Diabetic ... Read More
-
South Korea Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 1.18 billion by 2028, growing at a CAGR of 3.70% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 1 billion by 2027. The ... Read More
-
Saudi Arabia Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 2.65 billion by 2028, at a CAGR of 9% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 2.8 billion by 2027. The COVID-19 pandemic positively ... Read More
-
South Africa Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 375.50 million by 2028, at a CAGR of 2.46% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 380 million by 2027. The COVID-19 pandemic positively ... Read More
-
Japan Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 2.89 billion by 2028, at a CAGR of 4.60% during the forecast period (2023-2028). Japanese victims of the COVID-19 pandemic were less numerous than those from other nations, which may be related to genetic ... Read More
-
North America Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023 to USD 22.54 billion by 2028, at a CAGR of 4.70% during the forecast period (2023-2028). The COVID-19 pandemic had a favorable effect on the market for diabetes medications in North America. Diabetes and ... Read More
-
Human Insulin Drugs And Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023, and is expected to reach USD 78.08 billion by 2028, growing at a CAGR of 3.73% during the forecast period (2023-2028). Diabetes mellitus is considered a risk factor for increasing COVID-19. During the COVID-19 ... Read More
-
South Africa Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... is expected to reach USD 179 million by 2028, growing at a CAGR of 4.08% during the forecast period (2023-2028). and is estimated to reach around USD 172 million by 2027. The COVID-19 pandemic positively ... Read More
-
Middle East And Africa Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 2 billion in 2023 to USD 2.85 billion by 2028, at a CAGR of 4.12% during the forecast period (2023-2028). The market is estimated to reach a value of more than USD 2.7 billion ... Read More
Research Assistance
